HEADER APOPTOSIS 17-JUN-20 7CCL TITLE CRYSTAL STRUCTURE OF HUMAN BFK COMPND MOL_ID: 1; COMPND 2 MOLECULE: BCL-2-LIKE PROTEIN 15; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: BFK, BCL2-L-15; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BCL2L15, C1ORF178; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS BCL-2 FAMILY KIN, APOPTOSIS EXPDTA X-RAY DIFFRACTION AUTHOR D.M.JANG,E.K.OH,B.W.HAN REVDAT 3 29-NOV-23 7CCL 1 REMARK REVDAT 2 07-JUL-21 7CCL 1 REMARK REVDAT 1 23-JUN-21 7CCL 0 JRNL AUTH D.M.JANG,E.K.OH,B.W.HAN JRNL TITL STRUCTURAL ANALYSES ON HUMAN BFK, A NOVEL BCL-2 FAMILY JRNL TITL 2 MEMBER. JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0258 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.13 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 11434 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.158 REMARK 3 FREE R VALUE : 0.190 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.055 REMARK 3 FREE R VALUE TEST SET COUNT : 578 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.77 REMARK 3 REFLECTION IN BIN (WORKING SET) : 797 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.93 REMARK 3 BIN R VALUE (WORKING SET) : 0.2350 REMARK 3 BIN FREE R VALUE SET COUNT : 56 REMARK 3 BIN FREE R VALUE : 0.2690 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3306 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 11 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 64.35 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 17.98400 REMARK 3 B22 (A**2) : 17.98400 REMARK 3 B33 (A**2) : -35.96800 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.061 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.212 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 9.866 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.964 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.947 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3350 ; 0.005 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 3114 ; 0.003 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4534 ; 1.167 ; 1.627 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7238 ; 1.035 ; 1.564 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 428 ; 4.066 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 163 ;31.774 ;25.031 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 582 ;13.816 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 12 ;10.140 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 460 ; 0.022 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3755 ; 0.002 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 633 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 716 ; 0.156 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 91 ; 0.138 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1643 ; 0.133 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 70 ; 0.115 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1730 ; 0.647 ; 7.054 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1729 ; 0.647 ; 7.054 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2152 ; 1.227 ;10.575 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2153 ; 1.227 ;10.575 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1620 ; 0.311 ; 7.069 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1618 ; 0.311 ; 7.068 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2382 ; 0.669 ;10.582 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2382 ; 0.669 ;10.582 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TWIN DETAILS REMARK 3 NUMBER OF TWIN DOMAINS : 2 REMARK 3 TWIN DOMAIN : 1 REMARK 3 TWIN OPERATOR : H, K, L REMARK 3 TWIN FRACTION : 0.5386 REMARK 3 TWIN DOMAIN : 2 REMARK 3 TWIN OPERATOR : -H,-K,L REMARK 3 TWIN FRACTION : 0.4614 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK BULK SOLVENT REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THEIR REMARK 3 RIDING POSITIONS REMARK 4 REMARK 4 7CCL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 18-JUN-20. REMARK 100 THE DEPOSITION ID IS D_1300017380. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-JUN-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PAL/PLS REMARK 200 BEAMLINE : 5C (4A) REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97957 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11459 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.07700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.77 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 0.80900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.960 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 7CCM REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): NULL REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): NULL REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M BIS-TRIS PH 5.5, 28% PEG 3350, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 18.42000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 9.21000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -19 REMARK 465 GLY A -18 REMARK 465 SER A -17 REMARK 465 SER A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 SER A -9 REMARK 465 SER A -8 REMARK 465 GLY A -7 REMARK 465 LEU A -6 REMARK 465 VAL A -5 REMARK 465 PRO A -4 REMARK 465 ARG A -3 REMARK 465 GLY A -2 REMARK 465 SER A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 LYS A 2 REMARK 465 SER A 3 REMARK 465 SER A 4 REMARK 465 GLN A 5 REMARK 465 ARG A 32 REMARK 465 ASN A 33 REMARK 465 LEU A 34 REMARK 465 CYS A 35 REMARK 465 CYS A 36 REMARK 465 VAL A 37 REMARK 465 ASP A 38 REMARK 465 GLU A 39 REMARK 465 VAL A 40 REMARK 465 ASP A 41 REMARK 465 SER A 42 REMARK 465 GLY A 43 REMARK 465 GLU A 44 REMARK 465 PRO A 45 REMARK 465 CYS A 46 REMARK 465 SER A 47 REMARK 465 SER A 163 REMARK 465 MET B -19 REMARK 465 GLY B -18 REMARK 465 SER B -17 REMARK 465 SER B -16 REMARK 465 HIS B -15 REMARK 465 HIS B -14 REMARK 465 HIS B -13 REMARK 465 HIS B -12 REMARK 465 HIS B -11 REMARK 465 HIS B -10 REMARK 465 SER B -9 REMARK 465 SER B -8 REMARK 465 GLY B -7 REMARK 465 LEU B -6 REMARK 465 VAL B -5 REMARK 465 PRO B -4 REMARK 465 ARG B -3 REMARK 465 GLY B -2 REMARK 465 SER B -1 REMARK 465 HIS B 0 REMARK 465 MET B 1 REMARK 465 LYS B 2 REMARK 465 SER B 3 REMARK 465 SER B 4 REMARK 465 ARG B 32 REMARK 465 ASN B 33 REMARK 465 LEU B 34 REMARK 465 CYS B 35 REMARK 465 CYS B 36 REMARK 465 VAL B 37 REMARK 465 ASP B 38 REMARK 465 GLU B 39 REMARK 465 VAL B 40 REMARK 465 ASP B 41 REMARK 465 SER B 42 REMARK 465 GLY B 43 REMARK 465 SER B 163 REMARK 465 MET C -19 REMARK 465 GLY C -18 REMARK 465 SER C -17 REMARK 465 SER C -16 REMARK 465 HIS C -15 REMARK 465 HIS C -14 REMARK 465 HIS C -13 REMARK 465 HIS C -12 REMARK 465 HIS C -11 REMARK 465 HIS C -10 REMARK 465 SER C -9 REMARK 465 SER C -8 REMARK 465 GLY C -7 REMARK 465 LEU C -6 REMARK 465 VAL C -5 REMARK 465 PRO C -4 REMARK 465 ARG C -3 REMARK 465 GLY C -2 REMARK 465 SER C -1 REMARK 465 HIS C 0 REMARK 465 MET C 1 REMARK 465 LYS C 2 REMARK 465 SER C 3 REMARK 465 SER C 4 REMARK 465 ARG C 32 REMARK 465 ASN C 33 REMARK 465 LEU C 34 REMARK 465 CYS C 35 REMARK 465 CYS C 36 REMARK 465 VAL C 37 REMARK 465 ASP C 38 REMARK 465 GLU C 39 REMARK 465 VAL C 40 REMARK 465 ASP C 41 REMARK 465 SER C 42 REMARK 465 SER C 163 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 127 71.70 -153.21 REMARK 500 ALA C 127 68.64 -150.21 REMARK 500 REMARK 500 REMARK: NULL DBREF 7CCL A 1 163 UNP Q5TBC7 B2L15_HUMAN 1 163 DBREF 7CCL B 1 163 UNP Q5TBC7 B2L15_HUMAN 1 163 DBREF 7CCL C 1 163 UNP Q5TBC7 B2L15_HUMAN 1 163 SEQADV 7CCL MET A -19 UNP Q5TBC7 INITIATING METHIONINE SEQADV 7CCL GLY A -18 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL SER A -17 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL SER A -16 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL HIS A -15 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL HIS A -14 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL HIS A -13 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL HIS A -12 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL HIS A -11 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL HIS A -10 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL SER A -9 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL SER A -8 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL GLY A -7 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL LEU A -6 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL VAL A -5 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL PRO A -4 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL ARG A -3 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL GLY A -2 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL SER A -1 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL HIS A 0 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL MET B -19 UNP Q5TBC7 INITIATING METHIONINE SEQADV 7CCL GLY B -18 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL SER B -17 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL SER B -16 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL HIS B -15 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL HIS B -14 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL HIS B -13 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL HIS B -12 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL HIS B -11 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL HIS B -10 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL SER B -9 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL SER B -8 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL GLY B -7 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL LEU B -6 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL VAL B -5 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL PRO B -4 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL ARG B -3 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL GLY B -2 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL SER B -1 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL HIS B 0 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL MET C -19 UNP Q5TBC7 INITIATING METHIONINE SEQADV 7CCL GLY C -18 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL SER C -17 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL SER C -16 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL HIS C -15 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL HIS C -14 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL HIS C -13 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL HIS C -12 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL HIS C -11 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL HIS C -10 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL SER C -9 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL SER C -8 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL GLY C -7 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL LEU C -6 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL VAL C -5 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL PRO C -4 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL ARG C -3 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL GLY C -2 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL SER C -1 UNP Q5TBC7 EXPRESSION TAG SEQADV 7CCL HIS C 0 UNP Q5TBC7 EXPRESSION TAG SEQRES 1 A 183 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 183 LEU VAL PRO ARG GLY SER HIS MET LYS SER SER GLN THR SEQRES 3 A 183 PHE GLU GLU GLN THR GLU CYS ILE VAL ASN THR LEU LEU SEQRES 4 A 183 MET ASP PHE LEU SER PRO THR LEU GLN VAL ALA SER ARG SEQRES 5 A 183 ASN LEU CYS CYS VAL ASP GLU VAL ASP SER GLY GLU PRO SEQRES 6 A 183 CYS SER PHE ASP VAL ALA ILE ILE ALA GLY ARG LEU ARG SEQRES 7 A 183 MET LEU GLY ASP GLN PHE ASN GLY GLU LEU GLU ALA SER SEQRES 8 A 183 ALA LYS ASN VAL ILE ALA GLU THR ILE LYS GLY GLN THR SEQRES 9 A 183 GLY ALA ILE LEU GLN ASP THR VAL GLU SER LEU SER LYS SEQRES 10 A 183 THR TRP CYS ALA GLN ASP SER SER LEU ALA TYR GLU ARG SEQRES 11 A 183 ALA PHE LEU ALA VAL SER VAL LYS LEU LEU GLU TYR MET SEQRES 12 A 183 ALA HIS ILE ALA PRO GLU VAL VAL GLY GLN VAL ALA ILE SEQRES 13 A 183 PRO MET THR GLY MET ILE ASN GLY ASN GLN ALA ILE ARG SEQRES 14 A 183 GLU PHE ILE GLN GLY GLN GLY GLY TRP GLU ASN LEU GLU SEQRES 15 A 183 SER SEQRES 1 B 183 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 183 LEU VAL PRO ARG GLY SER HIS MET LYS SER SER GLN THR SEQRES 3 B 183 PHE GLU GLU GLN THR GLU CYS ILE VAL ASN THR LEU LEU SEQRES 4 B 183 MET ASP PHE LEU SER PRO THR LEU GLN VAL ALA SER ARG SEQRES 5 B 183 ASN LEU CYS CYS VAL ASP GLU VAL ASP SER GLY GLU PRO SEQRES 6 B 183 CYS SER PHE ASP VAL ALA ILE ILE ALA GLY ARG LEU ARG SEQRES 7 B 183 MET LEU GLY ASP GLN PHE ASN GLY GLU LEU GLU ALA SER SEQRES 8 B 183 ALA LYS ASN VAL ILE ALA GLU THR ILE LYS GLY GLN THR SEQRES 9 B 183 GLY ALA ILE LEU GLN ASP THR VAL GLU SER LEU SER LYS SEQRES 10 B 183 THR TRP CYS ALA GLN ASP SER SER LEU ALA TYR GLU ARG SEQRES 11 B 183 ALA PHE LEU ALA VAL SER VAL LYS LEU LEU GLU TYR MET SEQRES 12 B 183 ALA HIS ILE ALA PRO GLU VAL VAL GLY GLN VAL ALA ILE SEQRES 13 B 183 PRO MET THR GLY MET ILE ASN GLY ASN GLN ALA ILE ARG SEQRES 14 B 183 GLU PHE ILE GLN GLY GLN GLY GLY TRP GLU ASN LEU GLU SEQRES 15 B 183 SER SEQRES 1 C 183 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 C 183 LEU VAL PRO ARG GLY SER HIS MET LYS SER SER GLN THR SEQRES 3 C 183 PHE GLU GLU GLN THR GLU CYS ILE VAL ASN THR LEU LEU SEQRES 4 C 183 MET ASP PHE LEU SER PRO THR LEU GLN VAL ALA SER ARG SEQRES 5 C 183 ASN LEU CYS CYS VAL ASP GLU VAL ASP SER GLY GLU PRO SEQRES 6 C 183 CYS SER PHE ASP VAL ALA ILE ILE ALA GLY ARG LEU ARG SEQRES 7 C 183 MET LEU GLY ASP GLN PHE ASN GLY GLU LEU GLU ALA SER SEQRES 8 C 183 ALA LYS ASN VAL ILE ALA GLU THR ILE LYS GLY GLN THR SEQRES 9 C 183 GLY ALA ILE LEU GLN ASP THR VAL GLU SER LEU SER LYS SEQRES 10 C 183 THR TRP CYS ALA GLN ASP SER SER LEU ALA TYR GLU ARG SEQRES 11 C 183 ALA PHE LEU ALA VAL SER VAL LYS LEU LEU GLU TYR MET SEQRES 12 C 183 ALA HIS ILE ALA PRO GLU VAL VAL GLY GLN VAL ALA ILE SEQRES 13 C 183 PRO MET THR GLY MET ILE ASN GLY ASN GLN ALA ILE ARG SEQRES 14 C 183 GLU PHE ILE GLN GLY GLN GLY GLY TRP GLU ASN LEU GLU SEQRES 15 C 183 SER FORMUL 4 HOH *11(H2 O) HELIX 1 AA1 THR A 6 SER A 24 1 19 HELIX 2 AA2 SER A 24 SER A 31 1 8 HELIX 3 AA3 ASP A 49 ASP A 62 1 14 HELIX 4 AA4 LEU A 68 GLY A 82 1 15 HELIX 5 AA5 GLN A 83 GLN A 102 1 20 HELIX 6 AA6 ALA A 107 ALA A 127 1 21 HELIX 7 AA7 VAL A 130 GLN A 133 5 4 HELIX 8 AA8 VAL A 134 ASN A 145 1 12 HELIX 9 AA9 ASN A 145 GLN A 155 1 11 HELIX 10 AB1 GLY A 156 LEU A 161 5 6 HELIX 11 AB2 THR B 6 SER B 24 1 19 HELIX 12 AB3 SER B 24 SER B 31 1 8 HELIX 13 AB4 ASP B 49 ASP B 62 1 14 HELIX 14 AB5 LEU B 68 GLY B 82 1 15 HELIX 15 AB6 GLN B 83 ASP B 103 1 21 HELIX 16 AB7 ALA B 107 ALA B 127 1 21 HELIX 17 AB8 VAL B 130 GLN B 133 5 4 HELIX 18 AB9 VAL B 134 GLY B 144 1 11 HELIX 19 AC1 ASN B 145 GLN B 155 1 11 HELIX 20 AC2 THR C 6 SER C 24 1 19 HELIX 21 AC3 SER C 24 SER C 31 1 8 HELIX 22 AC4 ASP C 49 ASP C 62 1 14 HELIX 23 AC5 LEU C 68 GLY C 82 1 15 HELIX 24 AC6 GLN C 83 ASP C 103 1 21 HELIX 25 AC7 ALA C 107 ALA C 127 1 21 HELIX 26 AC8 VAL C 130 GLN C 133 5 4 HELIX 27 AC9 VAL C 134 ASN C 145 1 12 HELIX 28 AD1 ASN C 145 GLN C 155 1 11 HELIX 29 AD2 GLY C 156 LEU C 161 5 6 CRYST1 116.500 116.500 27.630 90.00 90.00 120.00 P 32 9 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008584 0.004956 0.000000 0.00000 SCALE2 0.000000 0.009912 0.000000 0.00000 SCALE3 0.000000 0.000000 0.036193 0.00000